Evidence map›Paper›PMID 29032433›Full record

ArticlePediatric nephrology (Berlin, Germany)2018

Diffuse mesangial sclerosis in a PDSS2 mutation-induced coenzyme Q10 deficiency.

Béla Iványi, Gábor Z Rácz, Péter Gál, Kitti Brinyiczki, István Bódi, Tibor Kalmár, Zoltán Maróti, Csaba Bereczki

Open access · greenAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Understanding coenzyme Q.Physiological reviews · 2024
    Review
  4. Primary Coenzyme Q10 Deficiency: An Update.Antioxidants (Basel, Switzerland) · 2023
    Review
  5. Biosynthesis, Deficiency, and Supplementation of Coenzyme Q.Antioxidants (Basel, Switzerland) · 2023
    Review
  6. Neuroimaging in Primary Coenzyme-QAntioxidants (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. A novelMolecular genetics and metabolism reports · 2022
    Article
  11. Review
  12. Disorders of Human Coenzyme Q10 Metabolism: An Overview.International journal of molecular sciences · 2020
    Review
  13. Redefining infantile-onset multisystem phenotypes of coenzyme QJournal of translational genetics and genomics · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Béla IványiDepartment of Pathology, Faculty of Medicine, University of Szeged, Állomás u. 1, Szeged, 6725, Hungary. ivanyi.bela@med.u-szeged.hu.
Gábor Z RáczDepartment of Pediatrics and Pediatric Health Center, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Péter GálDepartment of Pediatrics and Pediatric Health Center, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Kitti BrinyiczkiDepartment of Pathology, Faculty of Medicine, University of Szeged, Állomás u. 1, Szeged, 6725, Hungary.
István BódiKing's College Hospital, London, UK.
Tibor KalmárDepartment of Pediatrics and Pediatric Health Center, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Zoltán MarótiDepartment of Pediatrics and Pediatric Health Center, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Csaba BereczkiDepartment of Pediatrics and Pediatric Health Center, Faculty of Medicine, University of Szeged, Szeged, Hungary.
University of Szeged · HUKing's College Hospital · GB

Funding

National Research, Development and Innovation Office Hungary GINOP-2.3.2-15-2The National Research, Development and Innovation Office, HUNGARY GINOP-2.3.2-15-2
6 · The paper itself

Abstract

backgroundA 7-month-old male infant was admitted because he was suffering from nephrotic syndrome, along with encephalomyopathy, hypertrophic cardiomyopathy, clinically suspected deafness and retinitis pigmentosa, and an elevated serum lactate level.

methodsCoenzyme Q

resultsThe results of genetic tests, available postmortem, explored two hitherto undescribed mutations in the PDSS2 gene. Both were located within the polyprenyl synthetase domain. Clinical exome sequencing revealed a heterozygous missense mutation in exon 3, and our in-house joint-analysis algorithm detected a heterozygous large 2923-bp deletion that affected the 5 prime end of exon 8. Other causative defects in the CoQ

conclusionsUntil now, the clinical features and the mutational status of 6 patients with a PDSS2 gene defect have been reported in the English literature. Here, we describe for the first time detailed kidney morphology features in a patient with nephrotic syndrome carrying mutations in the PDSS2 gene.

Indexed as

Alkyl and Aryl TransferasesAtaxiaAutopsyFatal OutcomeGenetic TestingHumansInfantKidneyMaleMitochondrial DiseasesMuscle WeaknessMutationNephrotic SyndromeSclerosisUbiquinoneAlkyl and Aryl Transferasescoenzyme Q10prenyl diphosphate synthase, subunit 2, humanUbiquinoneCoQ10Diffuse mesangial sclerosisNephroticPDSS2

Identifiers

PMID29032433
OpenAlexW2761015912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.